Molecular and biopharmaceutical investigation of alginate–inulin synbiotic coencapsulation of probiotic to target the colon

Journal of Microencapsulation

Volumn 34, Issue 2, 2017, Pages 171-184

  Atia, Abdelbasset ^a,d   Gomma, Ahmed I ^a,b   Fliss, Ismail ^a   Beyssac, Eric ^c   Garrait, Ghislain ^c   Subirade, Muriel ^a  

^a UNIVERSITÉ LAVAL   (Canada)

^b NATIONAL RESEARCH CENTRE   (Egypt)

^c UNIVERSITÉ CLERMONT AUVERGNE   (France)

^d Biena Probiotics and Lactic Cultures   (Canada)

Author keywords

Colonic delivery; ex vivo mucoadhesiveness; inulin alginate beads; USP apparatus 4

Indexed keywords

ALGINIC ACID; INULIN; NANOBEAD; PROBIOTIC AGENT; SYNBIOTIC AGENT;

ARTICLE; BACTERIAL COUNT; BACTERIAL STRAIN; BACTERIAL SURVIVAL; CHEMICAL STRUCTURE; COLON; DRUG DELIVERY SYSTEM; DRUG RELEASE; DRUG SOLUBILITY; ENCAPSULATION; EX VIVO STUDY; IN VITRO STUDY; INFRARED SPECTROSCOPY; INTESTINE MUCOSA; LACTOBACILLUS REUTERI; LACTOBACILLUS SALIVARIUS; MOLECULAR INTERACTION; MUCOADHESION; NONHUMAN; PEDIOCOCCUS ACIDILACTICI; PHARMACEUTICS; POLYMERASE CHAIN REACTION; SCANNING ELECTRON MICROSCOPY; SURVIVAL RATE; TARGET ORGAN; DRUG DOSAGE FORM;

ALGINATES; COLON; DOSAGE FORMS; INULIN; PROBIOTICS; SYNBIOTICS;

EID: 85018516139     PISSN: 02652048     EISSN: 14645246     Source Type: Journal    
DOI: 10.1080/02652048.2017.1313330     Document Type: Article

References (72)

1. Anand O, Yu LX, Conner DP, Davit BM., Dissolution testing for generic drugs:an FDA perspective. AAPS J, 2011;13(3):328–35.
2. De Ascentiis A, DeGrazia JL, Bowman CN, Colombo P, Peppas NA., Mucoadhesion of poly (2-hydroxyethyl methacrylate) is improved when linear poly (ethylene oxide) chains are added to the polymer network’. J Controlled Release, 1995;33(1):197–201.
3. Ashford M, Fell J., Targeting drugs to the colon:Delivery systems for oral administration. J Drug Target, 1994;2(3):241–57.
4. Atia A, Lessard M, Beyssac E, Garrait G, Gomaa A, Fliss I, Subirade M., 2014. ‘« Les probiotiques et l’alimentation porcine.»’, in 6ième Colloque international francophone de microbiologie animale, École nationale vétérinaire de Toulouse, Toulouse.
5. Atuma C, Strugala V, Allen A, Holm L., ‘The adherent gastrointestinal mucus gel layer:thickness and physical state in vivo’. Am J Physiol Gastrointest Liver Physiol, 2001;280(5):G922–9.
6. AZZA AA., ‘Physico-chemical properties of inulin produced from Jerusalem artichoke tubers on bench and pilot plant scale’. Aust J Basic Appl Sci, 2010;5(5):1297–309.
7. Bajpai SK, Sharma S., Investigation of swelling/degradation behaviour of alginate beads crosslinked with Ca2+ and Ba2+ ions’. React Funct Polym, 2004;59(2):129–40.
8. Beyssac E, Lavigne J., Dissolution study of active pharmaceutical ingredients using the flow through apparatus USP 4. Dissol Technol, 2005;12(2):23–5.
9. Boddupalli BM, Mohammed ZNK, Nath RA, Banji D., Mucoadhesive drug delivery system:An overview. J Adv Pharm Technol Res, 2010;1(4):381–7.
10. Carvalho FC, Bruschi ML, Evangelista RC, Gremião MPD., Mucoadhesive drug delivery systems’. Braz J Pharm Sci, [Faculdade de Ciências Farmacêuticas da Universidade de São Paulo], 2010;46(1):1–17.
11. Clayden J, Greeves N, Warren S., 2012. Organic chemistry. Oxford:OUP.
12. Cook MT, Tzortzis G, Charalampopoulos D, Khutoryanskiy VV., Microencapsulation of probiotics for gastrointestinal delivery. J Controlled Release, 2012;56–67.
13. Daba H, Lacroix C, Huang J, Simard RE, Lemieux L., Simple method of purification and sequencing of a bacteriocin produced by Pediococcus acidilactici UL5. J Appl Bacteriol, 1994;77(6):682–8.
14. Daemi H, Barikani M., Synthesis and characterization of calcium alginate nanoparticles, sodium homopolymannuronate salt and its calcium nanoparticles’. Scientia Iranica, 2012;19(6):2023–8.
15. Davidovich-Pinhas M, Bianco-Peled H., Mucoadhesion:A review of characterization techniques. Expert Opin Drug Deliv, 2010;7:259–71.
16. Deladino L, Anbinder PS, Navarro AS, Martino MN., Encapsulation of natural antioxidants extracted from Ilex paraguariensis. Carbohydr Polym, 2008;71(1):126–34.
17. Direction Européenne de la Qualité du Médicament. 2014. 8e Édition Pharmacopée européenne.
18. Divya JB, Nampoothiri KM., ‘Encapsulated Lactococcus lactis with enhanced gastrointestinal survival for the development of folate enriched functional foods’. Bioresour Technol, 2015;188:226–30.
19. Draget K, Smidsrød O, Skjåk-Bræk G., ‘Alginates from algae’. Biopolymers Online, 2005;1–30. doi:10.1002/3527600035.bpol6008.
20. Fernandez B., 2014. Activité biologique et impact sur le microbiote intestinal des bactéries lactiques bactériocinogènes. Collection, Collection des thèses et mémoires électroniques de l’Université Laval. Collection. Edited by C. des thèses et mémoires électroniques de l’Université Laval. Collection des thèses et mémoires électroniques de l’Université Laval.
21. Figueroa-González I, Quijano G, Ramírez G, Cruz-Guerrero A., ‘Probiotics and prebiotics-perspectives and challenges’. J Sci Food Agr, 2011;91:1341–8.
22. Francis MF, Cristea M, Winnik FM., ‘Polymeric micelles for oral drug delivery:Why and how’. Pure Appl Chem, 2004;76(7–8):1321–35.
23. Frei R, Akdis M, O’Mahony L., Prebiotics, probiotics, synbiotics, and the immune system:experimental data and clinical evidence’. Curr Opin Gastroenterol, 2015;31(2):153–8.
24. Fujimoto J, Watanabe K., Quantitative detection of viable Bifidobacterium bifidum BF-1 cells in human feces by using propidium monoazide and strain-specific primers. Appl Environ Microbiol, 2013;79:2182–8.
25. Gao Z., In vitro dissolution testing with flow-through method:a technical note. AAPS PharmSciTech, 2009;10(4):1401–5.
26. Garrait G, Jarrige JF, Blanquet S, Beyssac E, Cardot JM, Alric M., Gastrointestinal absorption and urinary excretion of trans-cinnamic and p-coumaric acids in rats’. J Agr Food Chem, 2006;54:2944–50.
27. Gattani SG, Savaliya PJ, Belgamwar VS., Floating-mucoadhesive beads of clarithromycin for the treatment of Helicobacter pylori infection.’ Chem Pharm Bull, 2010;58:782–7.
28. Hansen CF, Phillips ND, La T, Hernandez A, Mansfield J, Kim JC, Mullan BP, Hampson DJ, Pluske JR., Diets containing inulin but not lupins help to prevent swine dysentery in experimentally challenged pigs’. J Animal Sci, 2010;88:3327–36.
29. Harrow SA, Ravindran V, Butler RC, Marshall JW, Tannock GW., Real-time quantitative PCR measurement of ileal Lactobacillus salivarius populations from broiler chickens to determine the influence of farming practices. Appl Environ Microbiol, 2007;73(22):7123–7.
30. Häuselmann HJ, Fernandes RJ, Mok SS, Schmid TM, Block JA, Aydelotte MB, Kuettner KE, Thonar EJ., ‘Phenotypic stability of bovine articular chondrocytes after long-term culture in alginate beads.’ J Cell Sci, 1994;107:17–27.
31. Heavens D, Tailford LE, Crossman L, Jeffers F, MacKenzie DA, Caccamo M, Juge N., Genome sequence of the vertebrate gut symbiont Lactobacillus reuteri ATCC 53608. J Bacteriol, 2011;193(15):4015–16.
32. Heng D, Cutler DJ, Chan HK, Yun J, Raper JA., What is a suitable dissolution method for drug nanoparticles? Pharm Res, 2008;25(7):1696–701.
33. Hombach J, Bernkop-Schnürch A., 2010. Mucoadhesive drug delivery systems. In:Monika Schäfer-Korting, M, ed. Drug delivery. Berlin, Heidelberg:Springer, pp. 251–66.
34. IFAH (2013) Overcoming barriers to animal disease prevention and control, a critical step towards One Health.
35. Iyer C, Kailasapathy K., ‘Effect of co-encapsulation of probiotics with prebiotics on increasing the viability of encapsulated bacteria under in vitro acidic and bile salt conditions and in yogurt’. J Food Sci, 2005;70:M18–23.
36. Josefsen MH, Löfström C, Hansen TB, Christensen LS, Olsen JE, Hoorfar J., Rapid quantification of viable Campylobacter bacteria on chicken carcasses, using real-time PCR and propidium monoazide treatment, as a tool for quantitative risk assessment. Appl Environ Microbiol, 2010;76(15):5097–104.
37. Joshi S, Patel P, Lin S, Madan PL., ‘Development of cross-linked alginate spheres by ionotropic gelation technique for controlled release of naproxen orally’. Asian J Pharm Sci, 2012;7:134–42.
38. Juge N., Microbial adhesins to gastrointestinal mucus. Trends Microbiol, 2012;20(1):30–9.
39. Khutoryanskiy VV., Advances in mucoadhesion and mucoadhesive polymers. Macromol Biosci, 2011;11:748–64.
40. Kim GB, Seo YM, Kim CH, Paik IK., Effect of dietary prebiotic supplementation on the performance, intestinal microflora, and immune response of broilers. Poult Sci, 2011;90(1):75–82.
41. Krause DO, Bhandari SK, House JD, Nyachoti CM., Response of nursery pigs to a synbiotic preparation of starch and an anti-Escherichia coli K88 probiotic. Appl Environ Microbiol, 2010;76(24):8192–200.
42. Kumar H, Salminen S, Verhagen H, Rowland I, Heimbach J, Bañares S, Young T, Nomoto K, Lalonde M., Novel probiotics and prebiotics:road to the market. Curr Opin Biotechnol, 2015;32:99–103.
43. Bekers M, Grube M, Upite D, Kaminska E, Aleksejs Danilevich UV., ‘Inulin syrup from dried Jerusalem artichoke’. Proc Latvia Univ Agr, 2008;21(315):116–21.
44. Mora D, Fortina MG, Parini C, Manachini PL., Identification of Pediococcus acidilactici and Pediococcus pentosaceus based on 16S rRNA and ldhD gene-targeted multiplex PCR analysis. FEMS Microbiol Lett, 2006;151(2):231–36. ‘
45. Nakamura F, Ohta R, Machida Y, Nagai T., In vitro and in vivo nasal mucoadhesion of some water-soluble polymers’. Int J Pharm, 1996;134:173–81.
46. Nekkanti V, Venkatesan N, Betageri GV., Proliposomes for oral delivery:Progress and challenges. Curr Pharm Biotechnol, 2015;16(4):303–12.
47. Patil AR, Shinde SS, Kakade PS, D’souza JI., ‘Lactobacillus model moiety a new era dosage form as nutraceuticals and therapeutic mediator’. Biotechnol Bioforensics, 2015;11–21.
48. Peppas NA, Sahlin JJ., Hydrogels as mucoadhesive and bioadhesive materials:A review. Biomaterials, 1996;17(16):1553–61.
49. Peppas NA, Thomas JB, McGinty J., Molecular aspects of mucoadhesive carrier development for drug delivery and improved absorption. J Biomater Sci, 2009;20(1):1–20.
50. Ponchel G, Touchard F, Duchêne D, Peppas NA., Bioadhesive analysis of controlled-release systems. I. Fracture and interpenetration analysis in poly(acrylic acid)-containing systems’. J Controlled Release, 1987;5(2):129–41.
51. Patil P, Chavanke MWD., 2012. Efficacy of Mucoadhesive Hydrogel Microparticles of Whey Protein and Alginate for Oral Insulin Delivery. Available at:http://www.ijppsjournal.com/Vol4Suppl4/4488.pdf. Accessed 11 December 2014.
52. ® Blood & Tissue Handbook, © 2006 QIAGEN.
53. Rao KV, Buri P., A novel in situ method to test polymers and coated microparticles for bioadhesion’. Int J Pharm, 1989;52(3):265–70.
54. Reid G., The growth potential for dairy probiotics. Int Dairy J, 2015;49:16–22.
55. Ritskes-Hoitinga M, Chwalibog A., 2002. Nutrient requirements, experimental design, and feeding schedules in animal experimentation, Handbook of Laboratory Animal Science:Essential Principles and Practices. Boca Raton, FL:CRC Press.
56. Ryan ET, Calderwood SB, Qadri F., Live attenuated oral cholera vaccines. Expert Rev Vaccines, 2006;5(4):483–94.
57. Sahasathian T, Praphairaksit N, Muangsin N., Mucoadhesive and floating chitosan-coated alginate beads for the controlled gastric release of amoxicillin’. Arch Pharm Res, 2010;33:889–99.
58. Sanders ME, Marco ML., Food formats for effective delivery of probiotics. Ann Rev Food Sci Technol, 2010;1:65–85.
59. Sastry SV, Nyshadham JR, Fix JA., Recent technological advances in oral drug delivery–A review’. Pharm Sci Technol Today, 2000;3(4):138–45.
60. Sathyabama S, Kumar MR, Devi PB, Vijayabharathi R, Priyadharisini VB., Co-encapsulation of probiotics with prebiotics on alginate matrix and its effect on viability in simulated gastric environment. Food Sci Technol, 2014;57(1):419–25.
61. Scheubel E., 2010. Predictive in vitro dissolution tools:Application during formulation development. Université d’Auvergne - Clermont-Ferrand I.
62. Shaikh R, Raj Singh TR, Garland MJ, Woolfson a. D, Donnelly RF., Mucoadhesive drug delivery systems.’ J Pharm Bioallied Sci, 2011;3:89–100.
63. Smrdel P, Bogataj M, Mrhar A., The influence of selected parameters on the size and shape of alginate beads prepared by ionotropic gelation’. Scientia Pharmaceutica, 2008;76(1):77.
64. Strebhardt K, Ullrich A. Paul Ehrlich's magic bullet concept:100 years of progress. Nat Rev Cancer, 2008;8(6):473–80.
65. Tadros MI., Controlled-release effervescent floating matrix tablets of ciprofloxacin hydrochloride:Development, optimization and in vitro-in vivo evaluation in healthy human volunteers’. Eur J Pharm Biopharm, 2010;74:332–9.
66. Tanja P-I, Lidija P-T, Anita G, Rumenka P, Jasmina H, Emil P, Trajce S, Kristina M., From optimization of synbiotic microparticles prepared by spray-drying to development of new functional carrot juice. Chem Indus Chem Eng Quart, 2014;20(4):549–64.
67. USP, C. 2013. The United States Pharmacopeia, Sterilization and Sterility Assurance of Compendial Articles, Good Manufacturing Practices. The U.S. Pharmacopeial Convention.
68. Lo Verso L, Lessard M, Talbot G, Subirade M, Fliss I., 2013. ‘«Isolation and antibacterial activity of potential probiotic bacteria from pig gastrointestinal tract.»’, in 6th Symposium of Swine and Poultry Infectious Diseases Research Center. Congrès de l’ACFAS Colloque 227 Le microbiote animal:une question d’équilibre, p. 45.
69. De Vrese M, Schrezenmeir J., ‘Probiotics, prebiotics, and synbiotics.’ Adv Biochem Eng/Biotechnol, 2008;111:1–66.
70. Joint, FAO. 2001. WHO Expert consultation on evaluation of health and nutritional properties of probiotics in food including powder milk with live lactic acid bacteria. Córdoba, Argentina. October 1–4.
71. Wixon SK, Smiler KL., 1997. Anesthesia and analgesia in rodents. In:Fish R, Danneman P, Brown M, Karas A, editors. Anesthesia and analgesia in laboratory animals. New York:Academic Press Inc., pp. 165–203.
72. Yu Z, Morrison M., ‘Improved extraction of PCR-quality community DNA from digesta and fecal samples.’ BioTechniques, 2004;36(5):808–12.